Tag: Global Health

Panel discussion: The threat of false friends fake medicines - Imminent risks to global health
New findings offer systemic solutions to address non-communicable diseases (NCDs) in low- and middle-income countries
IFPMA facts & figures 2012
WHO Executive Board, 132nd session IFPMA statement under agenda item 9.2
New report offers insights into the threats posed by falsified medicines and highlights
Open-ended meeting of member States (CEWG)
Health leaders gather at 26th IFPMA assembly
A shared commitment to improving global health
IFPMA event highlights: innovating together for global health
Research-based pharmaceutical industry welcomes progress on key global health issues at World Health Assembly
WHA 65 agenda item 13.13 on Substandard / spurious / falsely-labelled / falsified / counterfeit medical products
The New Frontiers of Biopharmaceutical Innovation
Developing world health partnership directory flyer
The changing landscape on access to medicines
IFPMA corporate brochure 2012
Delivering the promise of the decade of vaccines
Improving global health through pharmaceutical innovation
IFPMA welcomes Otsuka Pharmaceutical as new member to advance global health
Technology transfer: a collaborative approach to improve global health
Technology transfer: A collaborative approach to improve global health
The pharmaceutical industry and global health: facts & figures
WHPA health improvement card
A shared commitment to fight non-communicable disease
IFPMA companies undertaking 100+ R&D projects for diseases of the developing world
25th IFPMA assembly explores theme of “A shared commitment to global health”
IFPMA President calls on industry to continue MDG contributions beyond 2015
Maternal health MDG to WHO South East Asia region meeting
World Health Assembly on millennium development goals
Launch of IFPMA developing world health partnerships directory 2010
1 2

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Statement Immunization Incremental Innovation Influenza Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers